Blog

Clinical Trials on Sanofi – GSK Vaccine for COVID-19: Update

Combating the Corona virus through various means are underway. Development of COVID Vaccine by prominent pharmaceutical companies are in progress. The Vaccine (ClinicalTrials.gov Identifier: NCT04537208) being developed in collaboration with Sanofi and GSK has passed the pre-clinical trials and planned to begin its Phase I/II trials in the United States of America. They are expecting … Continue reading

September 3, 2020 COVID Treatment 0 Comment

Satralizumab for Treatment of Neuromyelitis Optica Spectrum Disorder

The rare auto-immune disease, Neuromyelitis Optica Spectrum Disorder (NMOSD/Devic Disease), is characterized by either optic neuritis or myelitis. It is a chronic disorder of the brain and spinal cord dominated by inflammation of the optic nerve and inflammation of the spinal cord. NMOSD is seen only when the innate defense mechanisms against the disease or … Continue reading

August 31, 2020 Pharmaceuticals 0 Comment

Hand Sanitizers Warning by FDA

As a preventive measure for COVID-19, it was suggested by many to use the hand sanitizers. The mushrooming of different brands of hand sanitizers with variable composition of alcohol content was witnessed. However quite a good number of hand sanitizers lead to lethal effects in number of people across the world. In this connection in … Continue reading

August 30, 2020 COVID Treatment 0 Comment

FDA Broadens Emergency Use Authorization of Remdesivir

For the unprecedented COVID-19 several drugs haven suggested as a precautionary through treatment. Novel drugs as well the re-purposing of the drugs is at their high to combat the COVID-19. Drugs like Hydroxychloroquine, anti-viral agents were indicated for its treatment. The drug Remdesivir emerged as the finest choice for treatment of the symptoms. The Gilead’s … Continue reading

August 29, 2020 Pharmaceuticals 0 Comment